Truist Securities Maintains Hold on PROCEPT BioRobotics, Raises Price Target to $24
Benzinga Newsdesk 38 minutes ago
Analyst RatingsNewsPrice Target
Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Hold and raises the price target from $21 to $24.
Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Hold and raises the price target from $21 to $24.